| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
|
J Clin Oncol
|
2006
|
5.78
|
|
2
|
Severe spruelike enteropathy associated with olmesartan.
|
Mayo Clin Proc
|
2012
|
3.60
|
|
3
|
Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression.
|
Cancer Res
|
2005
|
2.67
|
|
4
|
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.
|
Cancer
|
2005
|
2.49
|
|
5
|
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
|
Am J Pathol
|
2002
|
2.35
|
|
6
|
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
|
Clin Cancer Res
|
2003
|
2.28
|
|
7
|
Lymphocytic duodenosis and the spectrum of celiac disease.
|
Am J Gastroenterol
|
2009
|
2.26
|
|
8
|
The crosstalk of mTOR/S6K1 and Hedgehog pathways.
|
Cancer Cell
|
2012
|
2.02
|
|
9
|
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.
|
Am J Pathol
|
2002
|
1.96
|
|
10
|
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet.
|
Am J Gastroenterol
|
2010
|
1.88
|
|
11
|
Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
|
Clin Cancer Res
|
2004
|
1.84
|
|
12
|
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line.
|
Cancer Biol Ther
|
2008
|
1.83
|
|
13
|
Frequent CpG island methylation in serrated adenomas of the colorectum.
|
Am J Pathol
|
2003
|
1.82
|
|
14
|
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
|
Cancer
|
2004
|
1.75
|
|
15
|
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
|
Cancer
|
2007
|
1.73
|
|
16
|
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
|
Clin Cancer Res
|
2008
|
1.64
|
|
17
|
Clinical staging and survival in refractory celiac disease: a single center experience.
|
Gastroenterology
|
2008
|
1.63
|
|
18
|
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue.
|
Clin Gastroenterol Hepatol
|
2010
|
1.58
|
|
19
|
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.
|
J Gastrointest Surg
|
2003
|
1.56
|
|
20
|
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
|
J Clin Oncol
|
2006
|
1.55
|
|
21
|
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
|
Clin Cancer Res
|
2006
|
1.52
|
|
22
|
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
|
Am J Surg Pathol
|
2007
|
1.52
|
|
23
|
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States.
|
Blood
|
2014
|
1.50
|
|
24
|
Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases.
|
Arch Pathol Lab Med
|
2008
|
1.50
|
|
25
|
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils.
|
J Vasc Interv Radiol
|
2005
|
1.43
|
|
26
|
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma.
|
Mol Cancer Ther
|
2006
|
1.41
|
|
27
|
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
|
Clin Cancer Res
|
2005
|
1.38
|
|
28
|
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.
|
Am J Surg Pathol
|
2005
|
1.36
|
|
29
|
"Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction.
|
Am J Surg Pathol
|
2007
|
1.34
|
|
30
|
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
|
J Clin Oncol
|
2006
|
1.33
|
|
31
|
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study.
|
Am J Gastroenterol
|
2011
|
1.32
|
|
32
|
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.
|
J Clin Oncol
|
2005
|
1.30
|
|
33
|
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases.
|
Am J Surg Pathol
|
2009
|
1.29
|
|
34
|
Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
|
Mod Pathol
|
2003
|
1.26
|
|
35
|
BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
|
Am J Pathol
|
2005
|
1.23
|
|
36
|
Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology.
|
Am J Surg Pathol
|
2002
|
1.23
|
|
37
|
Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas.
|
Oncogene
|
2004
|
1.22
|
|
38
|
IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis.
|
Am J Surg Pathol
|
2010
|
1.22
|
|
39
|
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
|
Clin Cancer Res
|
2006
|
1.21
|
|
40
|
Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway.
|
Mod Pathol
|
2002
|
1.16
|
|
41
|
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
|
Cancer Res
|
2008
|
1.15
|
|
42
|
Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma.
|
Neoplasia
|
2008
|
1.15
|
|
43
|
Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
|
Mod Pathol
|
2003
|
1.14
|
|
44
|
Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy.
|
AIDS
|
2013
|
1.14
|
|
45
|
Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.
|
Am J Pathol
|
2002
|
1.12
|
|
46
|
Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway.
|
Hum Pathol
|
2002
|
1.12
|
|
47
|
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.
|
PLoS One
|
2008
|
1.12
|
|
48
|
The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
|
Cancer
|
2006
|
1.12
|
|
49
|
Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis.
|
Mod Pathol
|
2005
|
1.11
|
|
50
|
Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy.
|
Clin Cancer Res
|
2003
|
1.10
|
|
51
|
Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors.
|
Mod Pathol
|
2005
|
1.09
|
|
52
|
Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.
|
J Gastroenterol Hepatol
|
2013
|
1.08
|
|
53
|
The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.
|
Mayo Clin Proc
|
2010
|
1.08
|
|
54
|
Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.
|
Clin Cancer Res
|
2012
|
1.07
|
|
55
|
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.
|
J Thorac Oncol
|
2006
|
1.06
|
|
56
|
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
|
J Clin Oncol
|
2007
|
1.03
|
|
57
|
Fibrolamellar carcinomas are positive for CD68.
|
Mod Pathol
|
2010
|
1.03
|
|
58
|
Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
|
Hum Pathol
|
2003
|
1.02
|
|
59
|
Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy.
|
Cancer Biol Ther
|
2012
|
1.01
|
|
60
|
Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years.
|
J Clin Oncol
|
2005
|
1.01
|
|
61
|
Overexpression of caspase-3 in hepatocellular carcinomas.
|
Mod Pathol
|
2004
|
1.00
|
|
62
|
Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
|
Cancer
|
2008
|
0.99
|
|
63
|
Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma.
|
Cancer
|
2006
|
0.98
|
|
64
|
Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.98
|
|
65
|
Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis.
|
Mod Pathol
|
2002
|
0.97
|
|
66
|
Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability.
|
Am J Surg Pathol
|
2004
|
0.97
|
|
67
|
Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity.
|
Arch Pathol Lab Med
|
2010
|
0.96
|
|
68
|
Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention.
|
Carcinogenesis
|
2005
|
0.96
|
|
69
|
Decreased expression of gene cluster at chromosome 1q21 defines molecular subgroups of chemoradiotherapy response in esophageal cancers.
|
Clin Cancer Res
|
2007
|
0.95
|
|
70
|
Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer.
|
Clin Exp Metastasis
|
2005
|
0.93
|
|
71
|
Adverse prognostic impact of intratumor heterogeneous HER2 gene amplification in patients with esophageal adenocarcinoma.
|
J Clin Oncol
|
2012
|
0.93
|
|
72
|
Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas.
|
Mod Pathol
|
2003
|
0.93
|
|
73
|
Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma.
|
Mod Pathol
|
2013
|
0.92
|
|
74
|
Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome.
|
PLoS One
|
2011
|
0.92
|
|
75
|
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction.
|
Cancer
|
2004
|
0.92
|
|
76
|
Ki-67 and ProExC are useful immunohistochemical markers in esophageal squamous intraepithelial neoplasia.
|
Hum Pathol
|
2011
|
0.91
|
|
77
|
Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.90
|
|
78
|
Glypican-3 expression in gastrointestinal and pancreatic epithelial neoplasms.
|
Hum Pathol
|
2012
|
0.90
|
|
79
|
RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
|
Cancer Res
|
2006
|
0.89
|
|
80
|
Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.
|
Am J Pathol
|
2011
|
0.89
|
|
81
|
Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.
|
Ann Surg Oncol
|
2011
|
0.89
|
|
82
|
Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
|
Clin Cancer Res
|
2005
|
0.89
|
|
83
|
Mucosal colonization by metastatic carcinoma in the gastrointestinal tract: a potential mimic of primary neoplasia.
|
Am J Surg Pathol
|
2011
|
0.88
|
|
84
|
Tumor-suppressive effect of retinoid receptor-induced gene-1 (RRIG1) in esophageal cancer.
|
Cancer Res
|
2007
|
0.88
|
|
85
|
Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene.
|
Am J Pathol
|
2002
|
0.87
|
|
86
|
Microsatellite instability in intraductal papillary neoplasms of the biliary tract.
|
Mod Pathol
|
2002
|
0.86
|
|
87
|
Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus.
|
Oncol Lett
|
2012
|
0.86
|
|
88
|
Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.85
|
|
89
|
Population screening for barrett esophagus: a prospective randomized pilot study.
|
Mayo Clin Proc
|
2011
|
0.85
|
|
90
|
Significance of central perivenulitis in pediatric liver transplantation.
|
Am J Surg Pathol
|
2008
|
0.85
|
|
91
|
Human leukocyte antigen genetics and clinical features of self-treated patients on a gluten-free diet.
|
J Clin Gastroenterol
|
2013
|
0.84
|
|
92
|
Autoimmune gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands.
|
Mod Pathol
|
2002
|
0.84
|
|
93
|
Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer.
|
Cancer
|
2007
|
0.83
|
|
94
|
Association between ipilimumab and celiac disease.
|
Mayo Clin Proc
|
2013
|
0.82
|
|
95
|
Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas.
|
Gastroenterology
|
2003
|
0.82
|
|
96
|
Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience.
|
HPB (Oxford)
|
2014
|
0.82
|
|
97
|
Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic.
|
Dig Dis Sci
|
2011
|
0.82
|
|
98
|
Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer.
|
Gastric Cancer
|
2005
|
0.81
|
|
99
|
HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma.
|
Cancer
|
2013
|
0.81
|
|
100
|
For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?
|
J Clin Oncol
|
2007
|
0.81
|
|
101
|
Workflow-based Data Reconciliation for Clinical Decision Support: Case of Colorectal Cancer Screening and Surveillance.
|
AMIA Jt Summits Transl Sci Proc
|
2013
|
0.81
|
|
102
|
Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
|
Am J Surg Pathol
|
2012
|
0.80
|
|
103
|
The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.
|
Cancer
|
2006
|
0.80
|
|
104
|
Dedifferentiated liposarcoma arising in an esophageal polyp: a case report.
|
Case Rep Gastrointest Med
|
2012
|
0.80
|
|
105
|
Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
|
Oncogene
|
2004
|
0.80
|
|
106
|
High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
|
Hum Pathol
|
2012
|
0.79
|
|
107
|
Colchicine effect in a colonic hyperplastic polyp. A lesion mimicking serrated adenoma.
|
Arch Pathol Lab Med
|
2002
|
0.79
|
|
108
|
Biomarkers of response to preoperative chemoradiation in esophageal cancers.
|
Semin Oncol
|
2006
|
0.79
|
|
109
|
Globular hepatic amyloid is highly sensitive and specific for LECT2 amyloidosis.
|
Am J Surg Pathol
|
2015
|
0.79
|
|
110
|
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.78
|
|
111
|
Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps.
|
Am J Clin Pathol
|
2004
|
0.78
|
|
112
|
Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.
|
Endocr Pathol
|
2015
|
0.78
|
|
113
|
Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection.
|
Am J Surg Pathol
|
2011
|
0.77
|
|
114
|
Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma.
|
Cancer
|
2008
|
0.76
|
|
115
|
Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody.
|
J Neuroimmunol
|
2010
|
0.75
|
|
116
|
Increased immunoglobulin G4-positive plasma cells in collagenous sprue.
|
Hum Pathol
|
2013
|
0.75
|
|
117
|
Prognostic Significance of the Histologic Response of Perihilar Cholangiocarcinoma to Preoperative Neoadjuvant Chemoradiation in Liver Explants.
|
Am J Surg Pathol
|
2016
|
0.75
|
|
118
|
Comparison of 5 Immunohistochemical Markers of Hepatocellular Differentiation for the Diagnosis of Hepatocellular Carcinoma.
|
Arch Pathol Lab Med
|
2015
|
0.75
|
|
119
|
Immunostains Used to Subtype Hepatic Adenomas Do Not Distinguish Hepatic Adenomas From Hepatocellular Carcinomas.
|
Am J Surg Pathol
|
2016
|
0.75
|
|
120
|
Paget cells in the esophagus: assessment of their histopathologic features and near-universal association with underlying esophageal adenocarcinoma.
|
Am J Surg Pathol
|
2008
|
0.75
|
|
121
|
Polypoid esophageal adenocarcinoma--a clinicopathological variant of esophageal cancer?
|
Curr Surg
|
2005
|
0.75
|